Section 3(d) & 3(e) of Indian Patent Act I Shilpa Pise I IPR Series I Patent Agent Examination

Описание к видео Section 3(d) & 3(e) of Indian Patent Act I Shilpa Pise I IPR Series I Patent Agent Examination

Disclaimer -

Video is for educational purpose only. Copyright disclainer under section 107 of the copyright act 1976, allowance is made for "fair use" for purposes such as critics, comment, exploring ideas. Fair use is a use permitted by copyright statute that might otherwise be infringing non-profit, educational or personal use tips the balance in favor of fair use.

Thanks for watching...#lifonhub

Intellectual Property Rights Series (IPR Series) is for those who want to pursue their career in field of IPR for Patent Agent Examination, Trademark Agent Examination, PhD in IPR, interest in IPR #patentagentexamination2023 #trademarkagentexamination2023 #phdinipr
Subscribe lifon hub official channel:    / @lifonhub2546  
Like Lifon hub on Facebook: https://www.facebook.com/profile.php?...
Follow Lifon hub on Twitter:   / imsrnagpur  
Follow Lifon hub on Instagram: https://instagram.com/office.research...
Blogspot: https://imsreducation.blogspot.com/?m=1
Link of all videos
Exam notice Patent Agent Examination 2023 I Trademark Agent Examination 2023:    • Patent Agent Examination 2023 I Trade...  
Introduction Intellectual Property Rights:    • Intellectual Property Rights I Shilpa...  
History of Indian Patent Act 1970:    • History of Indian Patent Act 1970 I I...  
Trade Related Intellectual Property Rights:    • Trade Related Intellectual Property R...  
Section 29 to 34 of Indian Patent Act :    • Section 29 to 34 of Indian Patent Act...  
IMSR courses:    • Professional courses I IMSR I Shilpa ...  
Chapters
00:00- Introduction
01:15- Introduction to section 3(d)
02:34- Section 3(d) in Pharmaceutical sector
02:56- Novartis vs Union of India case (GLIVEC)
04:23- Intellectual Property Appelate Board (IPAB)
06:00- Roche pharmaceutical case (Ganciclovir)
07:13- Section 3(e)
08:18- Example of Section 3(e) DICLOTROY AQ* (Troikka pharmaceuticals vs Lincoln Pharmaceuticals)

#Section3d
#Section3e
#IndianPatentAct
#Pharmaceuticals
#PatentLaw
#IntellectualProperty
#GenericMedicine
#PatentabilityCriteria
#NoveltyRequirement
#InventiveStep
#TherapeuticEfficacy
#PublicInterest
#Evergreening

Комментарии

Информация по комментариям в разработке